04.03.2009 18:27:00

PDI, Inc. to Hold Fourth Quarter and Full Year 2008 Financial Results Conference Call on Wednesday, March 11, 2009

PDI, Inc. (NASDAQ:PDII), a pioneer in providing contract sales and commercialization services to the biopharmaceutical industry, today announced that it will release its fourth quarter and full year 2008 financial results on Wednesday, March 11, 2009 after the market close.

PDI will host an investment community conference call beginning at 4:30 p.m. Eastern time on March 11, 2009 to discuss these results and to answer questions.

To participate in the live conference call by telephone, please dial (866) 644-4654 from the U.S., or for international callers, please dial (706) 643-1203.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of PDI’s web site at http://www.pdi-inc.com. A replay will be available on the web site. A telephone replay will be available from 5:30 p.m. Eastern time on March 11, 2009 through 11:59 p.m. Eastern time on March 13, 2009 by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international) and entering conference ID number 88865012.

About PDI

PDI provides commercialization services for established and emerging biopharmaceutical companies. The Company is dedicated to maximizing the return on investment for its clients by providing strategic flexibility, sales, marketing and commercialization expertise.

PDI currently operates in three business segments: Sales Services, Marketing Services and Product Commercialization. Our sales services include Performance Sales Teams™, which are dedicated pharmaceutical sales force teams for specific customers; Select Access™, our targeted sales solution that leverages an existing sales force and infrastructure; and PDI ON DEMAND, a suite of innovative sales services that provide rapid, customized sales force solutions tailored to meet the local, regional and seasonal needs of our customers. Our marketing services include marketing research and consulting services through TVG, and promotional physician interaction programs through Pharmakon. Our product commercialization solutions leverage our considerable sales and marketing expertise to manage products throughout their lifecycles. PDI's experience extends across multiple therapeutic categories and includes office- and hospital-based initiatives.

For more information, please visit the Company’s website at www.pdi-inc.com.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu PDI Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu PDI Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 218,17 0,83%